BEAT logo

BEAT HeartBeam Inc

$0.5945
$0.0702
(10.73%)
Today
Closed $0.584
$0.0105
(1.80%)
After Hours
85

Extremely Bullish Sentiment

How do you feel about BEAT?

Loading...
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers HeartBeam (NASDAQ:BEAT) stock moved upwards by 70.5% to $0.74 during Monday's regular session. The market value of their outstanding shares is at $24.4 million. PDS Biotechnology (NASDAQ:PDSB) shares movedread more...
Benzinga
HeartBeam Gets FDA Breakthrough Designation
HeartBeam (NASDAQ:BEAT) scored a significant regulatory catalyst as the U.S. FDA granted Breakthrough Device Designation to the HeartBeam System for its potential use in assessing suspected heart attacks outside the hospital. The designation gives the company prioritized interaction with the FDA as it works toward a pivotal study and potential expansion of the device’s indication.
24-7 Market News
HeartBeam Receives FDA Breakthrough Device Designation for Heart Attack Assessment
HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for the HeartBeam System as a tool for assessing...
Business Wire
HeartBeam, Inc. Letter to Shareholders
HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today issued a letter to shareholders from its Executive Chairman Richard Ferrari, and President and Founder, Branislav Vajdic, PhD. Dear Fellow Shareholders...
Business Wire
HeartBeam Reports Second Quarter 2026 Results
HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, has reported its financial and operational results for the second quarter ended June 30, 2026. Second Quarter & Subsequent 2026 Operational Highlights In...
Business Wire
HeartBeam to Host Second Quarter 2026 Results Conference Call on Thursday, August 13, 2026 at 4:30 p.m. Eastern Time
HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, will hold a conference call on Thursday, August 13, 2026 at 4:30 p.m. Eastern time to discuss its results for the second quarter ended June 30, 2026, and will be...
Business Wire
Healthcare IT is the Next AI Growth Story: 3 Stocks to Buy Now
Healthcare IT is emerging as AI's next growth story as providers adopt AI to cut costs & improve care. Here we present three stocks that are likely to benefit.
Zacks
HeartBeam Awarded New U.S. Patent Expanding Acoustic Sensing and Fluid Monitoring Capabilities of Its Cable-Free ECG Device
HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced the allowance of a new U.S. patent that significantly expands the capabilities of its credit card-sized, cable-free ECG device. The patent covers...
Business Wire
Bet On These 5 Top-Ranked Stocks With Increasing P/E Ratios
Tap these five stocks, W, DHR, ISRG, BEAT and CSW, with rising P/E ratios to try out an out-of-the-box approach.
Zacks